Guohai Innovative CCI Capital
VC Fund
Shenzhen, China
Guohai Innovative CCI Capital is a financial investment management firm.
- Total investments:
- 38
- Last investment:
- Lead investor:
- 26%
Last updated:
For AI agents: llms.txt
Industries Guohai Innovative CCI Capital invests in
Stages Guohai Innovative CCI Capital invests in
Countries Guohai Innovative CCI Capital invests in
Round sizes
Round size
- Series A
- $1.6M–$14M
- Series B
- $2.9M–$62M
Investment Focus
Industry
- Health Care 8 (21%)
- Medical 6 (16%)
- Robotics 6 (16%)
- Biotechnology 4 (11%)
- Pharmaceutical 4 (11%)
Stage
- Series B 10 (26%)
- Series A 7 (18%)
- Seed 5 (13%)
- Angel 5 (13%)
- Series C 5 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| ScanArk builds Reality-to-Sim spatial data infrastructure by converting physical environments into executable, interactive 3D digital copies. The company develops hardware, such as proprietary spatial cameras, alongside three-dimensional reconstruction engines and spatial asset platforms. These environments generate native 3D Gaussian Splatting scenes containing spatial, physical, and semantic data used to train and evaluate embodied artificial intelligence and robotics. | Seed / Oct 08, 2026 | ||
| Robot++ is a research and development of intelligent robots company. | Series C / Jul 21, 2026 | ||
| Biovision Pharma is a biomedical enterprise focusing on the research and development of targeted radiopharmaceuticals (TRT) integrated with visual diagnosis and treatment. | $58.8M / Series B / May 18, 2026 | ||
|
Booster Robotics
|
Accelerating Evolution is a humanoid robotics company. It provides humanoid robots to AI firms and research institutes, as well as quick mass production and supply of standard items. | $146.5M / Venture - Series Unknown / Apr 17, 2026 | |
Rigerna
|
Rigerna develops unique small nucleic acid medicines and innovative nucleic acid therapies for nonliver tissues. | $29M / Seed / Mar 20, 2026 | |
| Lingyu Intelligence engages in the manufacturing and sales of industrial robots, intelligent robots and service consumer robots. | Seed / Mar 12, 2026 | ||
Zhongke Fifth Era
|
Zhongke Fifth Era focuses on new technology that builds a material foundation for embodied worlds and multimodal end-to-end large models, as well as intelligent robots. | $14M / Angel / Oct 24, 2025 | |
| Elios focuses on the development and application of technical products for pharmaceutical process technology. | $14M / Series A / Sep 28, 2025 | ||
| Remo-Telight offers a range of services for the commercial aerospace industry, including infrared remote sensing and space laser communication solutions. | Venture - Series Unknown / Jun 25, 2025 | ||
| Hesguard is a medical device developer and producer of high-end implantable medical devices related to ophthalmic diseases. | Venture - Series Unknown / Jul 22, 2024 | ||
| See all 38 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Guohai Innovative CCI Capital invest in?
Guohai Innovative CCI Capital invests primarily in Health Care, Medical and Robotics startups, most often at Series B and Series A stage. Most of the 38 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Guohai Innovative CCI Capital invest in?
Guohai Innovative CCI Capital typically joins rounds of $1.6M–$14M at Series A and $2.9M–$62M at Series B. These are whole funding-round sizes, not Guohai Innovative CCI Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Guohai Innovative CCI Capital took part in.
When did Guohai Innovative CCI Capital last invest?
The most recent investment recorded for Guohai Innovative CCI Capital closed in Oct 2026. Shizune tracks 38 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
